DelMar Pharmaceuticals (NSDQ:DMPI) announced pricing details of a $9 million public offering last week. The company priced 2.8 million shares and warrants to purchase an aggregate of 2.1 million shares of common stock at $3.25 apiece.
The offering’s warrants have an exercise price of $3.50 per share and have an term of exercise of 5 years, according to the Menlo Park, Calif.-based company. DelMar plans to use the proceeds of the offering for general corporate purposes.
Get the full story at our sister site, Drug Delivery Business News.
The post DelMar Pharmaceuticals prices $9m public offering appeared first on MassDevice.
from MassDevice http://ift.tt/2oK1dh6
Cap comentari:
Publica un comentari a l'entrada